C9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation
Deepti Lall(Cedars-Sinai Medical Center), Robert H. Baloh(Cedars-Sinai Medical Center), Daniel H. Geschwind(University of California, Los Angeles), Hayk Davtyan(University of California, Irvine), Ileana Lorenzini(Banner Sun Health Research Institute), Oksana Shelest(Cedars-Sinai Medical Center), Jesse Landeros(Cedars-Sinai Medical Center), Jason D. Ulrich(Hope Center for Neurological Disorders), Thomas A. Mota(Cedars-Sinai Medical Center), Thomas E. Mahan(Washington University in St. Louis), Jessica E. Rexach(University of California, Los Angeles), Mathew Blurton‐Jones(University of California, Irvine), Rita Sattler(Barrow Neurological Institute), David M. Holtzman(Hope Center for Neurological Disorders), Junwon Kim(University of Pennsylvania), Michael Vazquez(Cedars-Sinai Medical Center), A.K.M. Ghulam Muhammad(Cedars-Sinai Medical Center), Layla Ghaffari(Barrow Neurological Institute), Shaughn Bell(Cedars-Sinai Medical Center), Jacqueline G. O’Rourke(Cedars-Sinai Medical Center)
Cited by 145
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
|Immunity|2017|3k
Alzheimer disease
|Nature Reviews Disease Primers|2021|2.4k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k